- Home
- MIST vs PSNL Comparison
MIST vs PSNL Comparison
Compare MIST & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- PSNL
- Stock Information
- Founded
- MIST 2003
- PSNL 2011
- Country
- MIST Canada
- PSNL United States
- Employees
- MIST N/A
- PSNL N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- PSNL Medical Specialities
- Sector
- MIST Health Care
- PSNL Health Care
- Exchange
- MIST Nasdaq
- PSNL Nasdaq
- Market Cap
- MIST 89.8M
- PSNL 576.8M
- IPO Year
- MIST N/A
- PSNL 2019
- Fundamental
- Price
- MIST $1.94
- PSNL $7.32
- Analyst Decision
- MIST Strong Buy
- PSNL Strong Buy
- Analyst Count
- MIST 2
- PSNL 5
- Target Price
- MIST $7.50
- PSNL $8.00
- AVG Volume (30 Days)
- MIST 566.3K
- PSNL 1.7M
- Earning Date
- MIST 08-07-2025
- PSNL 08-06-2025
- Dividend Yield
- MIST N/A
- PSNL N/A
- EPS Growth
- MIST N/A
- PSNL N/A
- EPS
- MIST N/A
- PSNL N/A
- Revenue
- MIST N/A
- PSNL $85,694,000.00
- Revenue This Year
- MIST N/A
- PSNL $0.45
- Revenue Next Year
- MIST N/A
- PSNL $25.75
- P/E Ratio
- MIST N/A
- PSNL N/A
- Revenue Growth
- MIST N/A
- PSNL 15.57
- 52 Week Low
- MIST $0.63
- PSNL $1.19
- 52 Week High
- MIST $2.75
- PSNL $7.73
- Technical
- Relative Strength Index (RSI)
- MIST 65.73
- PSNL 79.86
- Support Level
- MIST $1.86
- PSNL $6.27
- Resistance Level
- MIST $1.97
- PSNL $7.03
- Average True Range (ATR)
- MIST 0.10
- PSNL 0.49
- MACD
- MIST 0.00
- PSNL 0.10
- Stochastic Oscillator
- MIST 80.00
- PSNL 94.69
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.